FitLife Brands, Inc. (FTLF) stock
FTLFNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/302% below fair value
$6.83+0.00 (0.00%)
Close on Nov 17, 2026Market cap $64.14MP/E 35.9Yield –
FitLife Brands operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
FitLife Brands's operating income for the twelve months ending Jun 30, 2026 was $3.90M. For fiscal 2025 it was $2.96M, down 77.5% from the year before. The highest annual figure on record is $13.12M in fiscal 2024.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.96M | -77.5% |
| FY2024 | Dec 31, 2024 | $13.12M | +73.8% |
| FY2023 | Dec 31, 2023 | $7.55M | +32.4% |
| FY2022 | Dec 31, 2022 | $5.70M | -8.5% |
| FY2021 | Dec 31, 2021 | $6.23M | +43.4% |
| FY2020 | Dec 31, 2020 | $4.35M | +74.3% |
| FY2019 | Dec 31, 2019 | $2.49M | +281.8% |
| FY2018 | Dec 31, 2018 | $653.00K | – |
| FY2017 | Dec 31, 2017 | -$8.95M | -1995.5% |
| FY2016 | Dec 31, 2016 | $472.27K | – |
| FY2015 | Dec 31, 2015 | -$1.09M | -158.8% |
| FY2014 | Dec 31, 2014 | $1.85M | +33.5% |
| FY2013 | Dec 31, 2013 | $1.39M | -26.2% |
| FY2012 | Dec 31, 2012 | $1.88M | +801.6% |
| FY2011 | Dec 31, 2011 | $208.66K | – |
| FY2010 | Dec 31, 2010 | -$3.10M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $3.36M | +16.5% |
| Q1 FY2026 | Mar 31, 2026 | $3.06M | -3.8% |
| Q4 FY2025 | Dec 31, 2025 | -$4.84M | -231.6% |
| Q3 FY2025 | Sep 30, 2025 | $2.32M | -31.4% |
| Q4 FY2024 | Dec 31, 2024 | $2.88M | +58.1% |
| Q3 FY2024 | Sep 30, 2024 | $3.18M | +28.8% |
| Q2 FY2024 | Jun 30, 2024 | $3.68M | +42.2% |
| Q1 FY2024 | Mar 31, 2024 | $3.38M | +402.4% |
| Q4 FY2023 | Dec 31, 2023 | $1.82M | +146.9% |
| Q3 FY2023 | Sep 30, 2023 | $2.47M | +60.3% |
| Q2 FY2023 | Jun 30, 2023 | $2.58M | +41.6% |
| Q1 FY2023 | Mar 31, 2023 | $673.00K | -57.8% |
| Q4 FY2022 | Dec 31, 2022 | $738.00K | -51.0% |
| Q3 FY2022 | Sep 30, 2022 | $1.54M | +7.7% |
| Q2 FY2022 | Jun 30, 2022 | $1.83M | -10.2% |
| Q1 FY2022 | Mar 31, 2022 | $1.60M | +26.6% |
| Q4 FY2021 | Dec 31, 2021 | $1.51M | +2.6% |
| Q3 FY2021 | Sep 30, 2021 | $1.43M | +2.6% |
| Q2 FY2021 | Jun 30, 2021 | $2.03M | – |
| Q1 FY2021 | Mar 31, 2021 | $1.26M | -15.6% |
| Q4 FY2020 | Dec 31, 2020 | $1.47M | +1132.8% |
| Q3 FY2020 | Sep 30, 2020 | $1.40M | +28.3% |
| Q2 FY2020 | Jun 30, 2020 | -$10.00K | -103.9% |
| Q1 FY2020 | Mar 31, 2020 | $1.49M | +45.2% |
| Q4 FY2019 | Dec 31, 2019 | $119.00K | – |
| Q3 FY2019 | Sep 30, 2019 | $1.09M | +168.4% |
| Q2 FY2019 | Jun 30, 2019 | $258.00K | +20.6% |
| Q1 FY2019 | Mar 31, 2019 | $1.03M | +367.7% |
| Q4 FY2018 | Dec 31, 2018 | -$204.00K | – |
| Q3 FY2018 | Sep 30, 2018 | $405.00K | – |
| Q2 FY2018 | Jun 30, 2018 | $214.00K | – |
| Q1 FY2018 | Mar 31, 2018 | $220.00K | – |
| Q4 FY2017 | Dec 31, 2017 | -$7.64M | – |
| Q3 FY2017 | Sep 30, 2017 | -$483.00K | – |
| Q2 FY2017 | Jun 30, 2017 | -$517.00K | -142.4% |
| Q1 FY2017 | Mar 31, 2017 | -$306.23K | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.31M | – |
| Q3 FY2016 | Sep 30, 2016 | -$358.45K | – |
| Q2 FY2016 | Jun 30, 2016 | $1.22M | – |
See a number that looks wrong?